Impact of Vasculitis on Employment and Income

NCT02476292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426

Last updated 2016-01-28

No results posted yet for this study

Summary

The purpose of this study is to learn about the impact of vasculitis on employment and income in patients with different systemic vasculitides. All patients enrolled in the Vasculitis Clinical Research Consortium (VCRC) Patient Contact Registry, living in USA or Canada, and followed for more than 1 year since the vasculitis diagnosis will be invited via email to participate in this study, based on an online survey.

Conditions

  • Vasculitis
  • Systemic Vasculitis
  • Behcet's Disease
  • CNS Vasculitis
  • Cryoglobulinemic Vasculitis
  • Eosinophilic Granulomatosis
  • Temporal Arteritis
  • Wegener Granulomatosis
  • Henoch-Schoenlein Purpura
  • Microscopic Polyangiitis
  • Polyarteritis Nodosa (PAN)
  • Takayasu's Arteritis
  • Urticarial Vasculitis

Interventions

OTHER

online questionnaire

The online questionnaire includes questions about vasculitis, employment and work status before diagnosis and over the course of the disease, work capacity and the financial impact of vasculitis.

Sponsors & Collaborators

  • University of Western Ontario, Canada

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • University of Toronto

    collaborator OTHER
  • University of South Florida

    lead OTHER

Principal Investigators

  • Christian Pagnoux, MD, MPH, MSc · University of Toronto

  • Peter A. Merkel, MD, MPH · University of Pennsylvania

  • Lillian Barra, MD, PhD · University of Western Ontario, Canada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02476292 on ClinicalTrials.gov